Medical Care
Global Dosage Form Development Service Market Research Report 2025
- Mar 11, 25
- ID: 12802
- Pages: 81
- Figures: 85
- Views: 24
The global market for Dosage Form Development Service was valued at US$ 1230 million in the year 2024 and is projected to reach a revised size of US$ 1815 million by 2031, growing at a CAGR of 5.8% during the forecast period.
Dosage form development service refers to research and development services provided to pharmaceutical companies or research institutions for drug dosage forms. Dosage form refers to the administration form of a drug, i.E., the form in which a drug is prepared for use by patients. Common dosage forms include tablets, capsules, injections, liquids, ointments, etc. The choice of dosage form has a significant impact on drug efficacy, stability, and patient acceptability. Dosage form development services typically include the screening and optimization of dosage forms, the design and adjustment of formulation recipes, and the research and optimization of production processes. Through dosage form development services, pharmaceutical companies can develop drug dosage forms that are more suitable for patient needs and clinical applications, improving drug efficacy and safety while reducing production costs. Additionally, these services can help companies obtain relevant patent protection, enhancing their market competitiveness.
North American market for Dosage Form Development Service is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Dosage Form Development Service is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Dosage Form Development Service in Oral Dosage Form is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Dosage Form Development Service include Ascendia, Recipharm, Aurigene Services, Pirama, Serán, SGS, NerPharMa, Scantox, Protheragen-ING, BDD Pharma, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Dosage Form Development Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dosage Form Development Service.
The Dosage Form Development Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Dosage Form Development Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Dosage Form Development Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Ascendia
Recipharm
Aurigene Services
Pirama
Serán
SGS
NerPharMa
Scantox
Protheragen-ING
BDD Pharma
Evonik
Dalton Pharma Services
Douglas
Corealis
Upperton
Segment by Type
Pre-Formulation Services
Late Phase Formulation Development Services
Segment by Application
Oral Dosage Form
Injectable Dosage Form
Transdermal Dosage Form
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Dosage Form Development Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Dosage form development service refers to research and development services provided to pharmaceutical companies or research institutions for drug dosage forms. Dosage form refers to the administration form of a drug, i.E., the form in which a drug is prepared for use by patients. Common dosage forms include tablets, capsules, injections, liquids, ointments, etc. The choice of dosage form has a significant impact on drug efficacy, stability, and patient acceptability. Dosage form development services typically include the screening and optimization of dosage forms, the design and adjustment of formulation recipes, and the research and optimization of production processes. Through dosage form development services, pharmaceutical companies can develop drug dosage forms that are more suitable for patient needs and clinical applications, improving drug efficacy and safety while reducing production costs. Additionally, these services can help companies obtain relevant patent protection, enhancing their market competitiveness.
North American market for Dosage Form Development Service is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Dosage Form Development Service is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Dosage Form Development Service in Oral Dosage Form is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Dosage Form Development Service include Ascendia, Recipharm, Aurigene Services, Pirama, Serán, SGS, NerPharMa, Scantox, Protheragen-ING, BDD Pharma, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Dosage Form Development Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dosage Form Development Service.
The Dosage Form Development Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Dosage Form Development Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Dosage Form Development Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Ascendia
Recipharm
Aurigene Services
Pirama
Serán
SGS
NerPharMa
Scantox
Protheragen-ING
BDD Pharma
Evonik
Dalton Pharma Services
Douglas
Corealis
Upperton
Segment by Type
Pre-Formulation Services
Late Phase Formulation Development Services
Segment by Application
Oral Dosage Form
Injectable Dosage Form
Transdermal Dosage Form
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Dosage Form Development Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Dosage Form Development Service Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Pre-Formulation Services
1.2.3 Late Phase Formulation Development Services
1.3 Market by Application
1.3.1 Global Dosage Form Development Service Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Oral Dosage Form
1.3.3 Injectable Dosage Form
1.3.4 Transdermal Dosage Form
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Dosage Form Development Service Market Perspective (2020-2031)
2.2 Global Dosage Form Development Service Growth Trends by Region
2.2.1 Global Dosage Form Development Service Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Dosage Form Development Service Historic Market Size by Region (2020-2025)
2.2.3 Dosage Form Development Service Forecasted Market Size by Region (2026-2031)
2.3 Dosage Form Development Service Market Dynamics
2.3.1 Dosage Form Development Service Industry Trends
2.3.2 Dosage Form Development Service Market Drivers
2.3.3 Dosage Form Development Service Market Challenges
2.3.4 Dosage Form Development Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Dosage Form Development Service Players by Revenue
3.1.1 Global Top Dosage Form Development Service Players by Revenue (2020-2025)
3.1.2 Global Dosage Form Development Service Revenue Market Share by Players (2020-2025)
3.2 Global Dosage Form Development Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Dosage Form Development Service Revenue
3.4 Global Dosage Form Development Service Market Concentration Ratio
3.4.1 Global Dosage Form Development Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Dosage Form Development Service Revenue in 2024
3.5 Global Key Players of Dosage Form Development Service Head office and Area Served
3.6 Global Key Players of Dosage Form Development Service, Product and Application
3.7 Global Key Players of Dosage Form Development Service, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Dosage Form Development Service Breakdown Data by Type
4.1 Global Dosage Form Development Service Historic Market Size by Type (2020-2025)
4.2 Global Dosage Form Development Service Forecasted Market Size by Type (2026-2031)
5 Dosage Form Development Service Breakdown Data by Application
5.1 Global Dosage Form Development Service Historic Market Size by Application (2020-2025)
5.2 Global Dosage Form Development Service Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Dosage Form Development Service Market Size (2020-2031)
6.2 North America Dosage Form Development Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Dosage Form Development Service Market Size by Country (2020-2025)
6.4 North America Dosage Form Development Service Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Dosage Form Development Service Market Size (2020-2031)
7.2 Europe Dosage Form Development Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Dosage Form Development Service Market Size by Country (2020-2025)
7.4 Europe Dosage Form Development Service Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Dosage Form Development Service Market Size (2020-2031)
8.2 Asia-Pacific Dosage Form Development Service Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Dosage Form Development Service Market Size by Region (2020-2025)
8.4 Asia-Pacific Dosage Form Development Service Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Dosage Form Development Service Market Size (2020-2031)
9.2 Latin America Dosage Form Development Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Dosage Form Development Service Market Size by Country (2020-2025)
9.4 Latin America Dosage Form Development Service Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Dosage Form Development Service Market Size (2020-2031)
10.2 Middle East & Africa Dosage Form Development Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Dosage Form Development Service Market Size by Country (2020-2025)
10.4 Middle East & Africa Dosage Form Development Service Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Ascendia
11.1.1 Ascendia Company Details
11.1.2 Ascendia Business Overview
11.1.3 Ascendia Dosage Form Development Service Introduction
11.1.4 Ascendia Revenue in Dosage Form Development Service Business (2020-2025)
11.1.5 Ascendia Recent Development
11.2 Recipharm
11.2.1 Recipharm Company Details
11.2.2 Recipharm Business Overview
11.2.3 Recipharm Dosage Form Development Service Introduction
11.2.4 Recipharm Revenue in Dosage Form Development Service Business (2020-2025)
11.2.5 Recipharm Recent Development
11.3 Aurigene Services
11.3.1 Aurigene Services Company Details
11.3.2 Aurigene Services Business Overview
11.3.3 Aurigene Services Dosage Form Development Service Introduction
11.3.4 Aurigene Services Revenue in Dosage Form Development Service Business (2020-2025)
11.3.5 Aurigene Services Recent Development
11.4 Pirama
11.4.1 Pirama Company Details
11.4.2 Pirama Business Overview
11.4.3 Pirama Dosage Form Development Service Introduction
11.4.4 Pirama Revenue in Dosage Form Development Service Business (2020-2025)
11.4.5 Pirama Recent Development
11.5 Serán
11.5.1 Serán Company Details
11.5.2 Serán Business Overview
11.5.3 Serán Dosage Form Development Service Introduction
11.5.4 Serán Revenue in Dosage Form Development Service Business (2020-2025)
11.5.5 Serán Recent Development
11.6 SGS
11.6.1 SGS Company Details
11.6.2 SGS Business Overview
11.6.3 SGS Dosage Form Development Service Introduction
11.6.4 SGS Revenue in Dosage Form Development Service Business (2020-2025)
11.6.5 SGS Recent Development
11.7 NerPharMa
11.7.1 NerPharMa Company Details
11.7.2 NerPharMa Business Overview
11.7.3 NerPharMa Dosage Form Development Service Introduction
11.7.4 NerPharMa Revenue in Dosage Form Development Service Business (2020-2025)
11.7.5 NerPharMa Recent Development
11.8 Scantox
11.8.1 Scantox Company Details
11.8.2 Scantox Business Overview
11.8.3 Scantox Dosage Form Development Service Introduction
11.8.4 Scantox Revenue in Dosage Form Development Service Business (2020-2025)
11.8.5 Scantox Recent Development
11.9 Protheragen-ING
11.9.1 Protheragen-ING Company Details
11.9.2 Protheragen-ING Business Overview
11.9.3 Protheragen-ING Dosage Form Development Service Introduction
11.9.4 Protheragen-ING Revenue in Dosage Form Development Service Business (2020-2025)
11.9.5 Protheragen-ING Recent Development
11.10 BDD Pharma
11.10.1 BDD Pharma Company Details
11.10.2 BDD Pharma Business Overview
11.10.3 BDD Pharma Dosage Form Development Service Introduction
11.10.4 BDD Pharma Revenue in Dosage Form Development Service Business (2020-2025)
11.10.5 BDD Pharma Recent Development
11.11 Evonik
11.11.1 Evonik Company Details
11.11.2 Evonik Business Overview
11.11.3 Evonik Dosage Form Development Service Introduction
11.11.4 Evonik Revenue in Dosage Form Development Service Business (2020-2025)
11.11.5 Evonik Recent Development
11.12 Dalton Pharma Services
11.12.1 Dalton Pharma Services Company Details
11.12.2 Dalton Pharma Services Business Overview
11.12.3 Dalton Pharma Services Dosage Form Development Service Introduction
11.12.4 Dalton Pharma Services Revenue in Dosage Form Development Service Business (2020-2025)
11.12.5 Dalton Pharma Services Recent Development
11.13 Douglas
11.13.1 Douglas Company Details
11.13.2 Douglas Business Overview
11.13.3 Douglas Dosage Form Development Service Introduction
11.13.4 Douglas Revenue in Dosage Form Development Service Business (2020-2025)
11.13.5 Douglas Recent Development
11.14 Corealis
11.14.1 Corealis Company Details
11.14.2 Corealis Business Overview
11.14.3 Corealis Dosage Form Development Service Introduction
11.14.4 Corealis Revenue in Dosage Form Development Service Business (2020-2025)
11.14.5 Corealis Recent Development
11.15 Upperton
11.15.1 Upperton Company Details
11.15.2 Upperton Business Overview
11.15.3 Upperton Dosage Form Development Service Introduction
11.15.4 Upperton Revenue in Dosage Form Development Service Business (2020-2025)
11.15.5 Upperton Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Dosage Form Development Service Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Pre-Formulation Services
1.2.3 Late Phase Formulation Development Services
1.3 Market by Application
1.3.1 Global Dosage Form Development Service Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Oral Dosage Form
1.3.3 Injectable Dosage Form
1.3.4 Transdermal Dosage Form
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Dosage Form Development Service Market Perspective (2020-2031)
2.2 Global Dosage Form Development Service Growth Trends by Region
2.2.1 Global Dosage Form Development Service Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Dosage Form Development Service Historic Market Size by Region (2020-2025)
2.2.3 Dosage Form Development Service Forecasted Market Size by Region (2026-2031)
2.3 Dosage Form Development Service Market Dynamics
2.3.1 Dosage Form Development Service Industry Trends
2.3.2 Dosage Form Development Service Market Drivers
2.3.3 Dosage Form Development Service Market Challenges
2.3.4 Dosage Form Development Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Dosage Form Development Service Players by Revenue
3.1.1 Global Top Dosage Form Development Service Players by Revenue (2020-2025)
3.1.2 Global Dosage Form Development Service Revenue Market Share by Players (2020-2025)
3.2 Global Dosage Form Development Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Dosage Form Development Service Revenue
3.4 Global Dosage Form Development Service Market Concentration Ratio
3.4.1 Global Dosage Form Development Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Dosage Form Development Service Revenue in 2024
3.5 Global Key Players of Dosage Form Development Service Head office and Area Served
3.6 Global Key Players of Dosage Form Development Service, Product and Application
3.7 Global Key Players of Dosage Form Development Service, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Dosage Form Development Service Breakdown Data by Type
4.1 Global Dosage Form Development Service Historic Market Size by Type (2020-2025)
4.2 Global Dosage Form Development Service Forecasted Market Size by Type (2026-2031)
5 Dosage Form Development Service Breakdown Data by Application
5.1 Global Dosage Form Development Service Historic Market Size by Application (2020-2025)
5.2 Global Dosage Form Development Service Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Dosage Form Development Service Market Size (2020-2031)
6.2 North America Dosage Form Development Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Dosage Form Development Service Market Size by Country (2020-2025)
6.4 North America Dosage Form Development Service Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Dosage Form Development Service Market Size (2020-2031)
7.2 Europe Dosage Form Development Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Dosage Form Development Service Market Size by Country (2020-2025)
7.4 Europe Dosage Form Development Service Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Dosage Form Development Service Market Size (2020-2031)
8.2 Asia-Pacific Dosage Form Development Service Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Dosage Form Development Service Market Size by Region (2020-2025)
8.4 Asia-Pacific Dosage Form Development Service Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Dosage Form Development Service Market Size (2020-2031)
9.2 Latin America Dosage Form Development Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Dosage Form Development Service Market Size by Country (2020-2025)
9.4 Latin America Dosage Form Development Service Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Dosage Form Development Service Market Size (2020-2031)
10.2 Middle East & Africa Dosage Form Development Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Dosage Form Development Service Market Size by Country (2020-2025)
10.4 Middle East & Africa Dosage Form Development Service Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Ascendia
11.1.1 Ascendia Company Details
11.1.2 Ascendia Business Overview
11.1.3 Ascendia Dosage Form Development Service Introduction
11.1.4 Ascendia Revenue in Dosage Form Development Service Business (2020-2025)
11.1.5 Ascendia Recent Development
11.2 Recipharm
11.2.1 Recipharm Company Details
11.2.2 Recipharm Business Overview
11.2.3 Recipharm Dosage Form Development Service Introduction
11.2.4 Recipharm Revenue in Dosage Form Development Service Business (2020-2025)
11.2.5 Recipharm Recent Development
11.3 Aurigene Services
11.3.1 Aurigene Services Company Details
11.3.2 Aurigene Services Business Overview
11.3.3 Aurigene Services Dosage Form Development Service Introduction
11.3.4 Aurigene Services Revenue in Dosage Form Development Service Business (2020-2025)
11.3.5 Aurigene Services Recent Development
11.4 Pirama
11.4.1 Pirama Company Details
11.4.2 Pirama Business Overview
11.4.3 Pirama Dosage Form Development Service Introduction
11.4.4 Pirama Revenue in Dosage Form Development Service Business (2020-2025)
11.4.5 Pirama Recent Development
11.5 Serán
11.5.1 Serán Company Details
11.5.2 Serán Business Overview
11.5.3 Serán Dosage Form Development Service Introduction
11.5.4 Serán Revenue in Dosage Form Development Service Business (2020-2025)
11.5.5 Serán Recent Development
11.6 SGS
11.6.1 SGS Company Details
11.6.2 SGS Business Overview
11.6.3 SGS Dosage Form Development Service Introduction
11.6.4 SGS Revenue in Dosage Form Development Service Business (2020-2025)
11.6.5 SGS Recent Development
11.7 NerPharMa
11.7.1 NerPharMa Company Details
11.7.2 NerPharMa Business Overview
11.7.3 NerPharMa Dosage Form Development Service Introduction
11.7.4 NerPharMa Revenue in Dosage Form Development Service Business (2020-2025)
11.7.5 NerPharMa Recent Development
11.8 Scantox
11.8.1 Scantox Company Details
11.8.2 Scantox Business Overview
11.8.3 Scantox Dosage Form Development Service Introduction
11.8.4 Scantox Revenue in Dosage Form Development Service Business (2020-2025)
11.8.5 Scantox Recent Development
11.9 Protheragen-ING
11.9.1 Protheragen-ING Company Details
11.9.2 Protheragen-ING Business Overview
11.9.3 Protheragen-ING Dosage Form Development Service Introduction
11.9.4 Protheragen-ING Revenue in Dosage Form Development Service Business (2020-2025)
11.9.5 Protheragen-ING Recent Development
11.10 BDD Pharma
11.10.1 BDD Pharma Company Details
11.10.2 BDD Pharma Business Overview
11.10.3 BDD Pharma Dosage Form Development Service Introduction
11.10.4 BDD Pharma Revenue in Dosage Form Development Service Business (2020-2025)
11.10.5 BDD Pharma Recent Development
11.11 Evonik
11.11.1 Evonik Company Details
11.11.2 Evonik Business Overview
11.11.3 Evonik Dosage Form Development Service Introduction
11.11.4 Evonik Revenue in Dosage Form Development Service Business (2020-2025)
11.11.5 Evonik Recent Development
11.12 Dalton Pharma Services
11.12.1 Dalton Pharma Services Company Details
11.12.2 Dalton Pharma Services Business Overview
11.12.3 Dalton Pharma Services Dosage Form Development Service Introduction
11.12.4 Dalton Pharma Services Revenue in Dosage Form Development Service Business (2020-2025)
11.12.5 Dalton Pharma Services Recent Development
11.13 Douglas
11.13.1 Douglas Company Details
11.13.2 Douglas Business Overview
11.13.3 Douglas Dosage Form Development Service Introduction
11.13.4 Douglas Revenue in Dosage Form Development Service Business (2020-2025)
11.13.5 Douglas Recent Development
11.14 Corealis
11.14.1 Corealis Company Details
11.14.2 Corealis Business Overview
11.14.3 Corealis Dosage Form Development Service Introduction
11.14.4 Corealis Revenue in Dosage Form Development Service Business (2020-2025)
11.14.5 Corealis Recent Development
11.15 Upperton
11.15.1 Upperton Company Details
11.15.2 Upperton Business Overview
11.15.3 Upperton Dosage Form Development Service Introduction
11.15.4 Upperton Revenue in Dosage Form Development Service Business (2020-2025)
11.15.5 Upperton Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Dosage Form Development Service Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Pre-Formulation Services
Table 3. Key Players of Late Phase Formulation Development Services
Table 4. Global Dosage Form Development Service Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Dosage Form Development Service Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Dosage Form Development Service Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Dosage Form Development Service Market Share by Region (2020-2025)
Table 8. Global Dosage Form Development Service Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Dosage Form Development Service Market Share by Region (2026-2031)
Table 10. Dosage Form Development Service Market Trends
Table 11. Dosage Form Development Service Market Drivers
Table 12. Dosage Form Development Service Market Challenges
Table 13. Dosage Form Development Service Market Restraints
Table 14. Global Dosage Form Development Service Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Dosage Form Development Service Market Share by Players (2020-2025)
Table 16. Global Top Dosage Form Development Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dosage Form Development Service as of 2024)
Table 17. Ranking of Global Top Dosage Form Development Service Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Dosage Form Development Service Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Dosage Form Development Service, Headquarters and Area Served
Table 20. Global Key Players of Dosage Form Development Service, Product and Application
Table 21. Global Key Players of Dosage Form Development Service, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Dosage Form Development Service Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Dosage Form Development Service Revenue Market Share by Type (2020-2025)
Table 25. Global Dosage Form Development Service Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Dosage Form Development Service Revenue Market Share by Type (2026-2031)
Table 27. Global Dosage Form Development Service Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Dosage Form Development Service Revenue Market Share by Application (2020-2025)
Table 29. Global Dosage Form Development Service Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Dosage Form Development Service Revenue Market Share by Application (2026-2031)
Table 31. North America Dosage Form Development Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Dosage Form Development Service Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Dosage Form Development Service Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Dosage Form Development Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Dosage Form Development Service Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Dosage Form Development Service Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Dosage Form Development Service Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Dosage Form Development Service Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Dosage Form Development Service Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Dosage Form Development Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Dosage Form Development Service Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Dosage Form Development Service Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Dosage Form Development Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Dosage Form Development Service Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Dosage Form Development Service Market Size by Country (2026-2031) & (US$ Million)
Table 46. Ascendia Company Details
Table 47. Ascendia Business Overview
Table 48. Ascendia Dosage Form Development Service Product
Table 49. Ascendia Revenue in Dosage Form Development Service Business (2020-2025) & (US$ Million)
Table 50. Ascendia Recent Development
Table 51. Recipharm Company Details
Table 52. Recipharm Business Overview
Table 53. Recipharm Dosage Form Development Service Product
Table 54. Recipharm Revenue in Dosage Form Development Service Business (2020-2025) & (US$ Million)
Table 55. Recipharm Recent Development
Table 56. Aurigene Services Company Details
Table 57. Aurigene Services Business Overview
Table 58. Aurigene Services Dosage Form Development Service Product
Table 59. Aurigene Services Revenue in Dosage Form Development Service Business (2020-2025) & (US$ Million)
Table 60. Aurigene Services Recent Development
Table 61. Pirama Company Details
Table 62. Pirama Business Overview
Table 63. Pirama Dosage Form Development Service Product
Table 64. Pirama Revenue in Dosage Form Development Service Business (2020-2025) & (US$ Million)
Table 65. Pirama Recent Development
Table 66. Serán Company Details
Table 67. Serán Business Overview
Table 68. Serán Dosage Form Development Service Product
Table 69. Serán Revenue in Dosage Form Development Service Business (2020-2025) & (US$ Million)
Table 70. Serán Recent Development
Table 71. SGS Company Details
Table 72. SGS Business Overview
Table 73. SGS Dosage Form Development Service Product
Table 74. SGS Revenue in Dosage Form Development Service Business (2020-2025) & (US$ Million)
Table 75. SGS Recent Development
Table 76. NerPharMa Company Details
Table 77. NerPharMa Business Overview
Table 78. NerPharMa Dosage Form Development Service Product
Table 79. NerPharMa Revenue in Dosage Form Development Service Business (2020-2025) & (US$ Million)
Table 80. NerPharMa Recent Development
Table 81. Scantox Company Details
Table 82. Scantox Business Overview
Table 83. Scantox Dosage Form Development Service Product
Table 84. Scantox Revenue in Dosage Form Development Service Business (2020-2025) & (US$ Million)
Table 85. Scantox Recent Development
Table 86. Protheragen-ING Company Details
Table 87. Protheragen-ING Business Overview
Table 88. Protheragen-ING Dosage Form Development Service Product
Table 89. Protheragen-ING Revenue in Dosage Form Development Service Business (2020-2025) & (US$ Million)
Table 90. Protheragen-ING Recent Development
Table 91. BDD Pharma Company Details
Table 92. BDD Pharma Business Overview
Table 93. BDD Pharma Dosage Form Development Service Product
Table 94. BDD Pharma Revenue in Dosage Form Development Service Business (2020-2025) & (US$ Million)
Table 95. BDD Pharma Recent Development
Table 96. Evonik Company Details
Table 97. Evonik Business Overview
Table 98. Evonik Dosage Form Development Service Product
Table 99. Evonik Revenue in Dosage Form Development Service Business (2020-2025) & (US$ Million)
Table 100. Evonik Recent Development
Table 101. Dalton Pharma Services Company Details
Table 102. Dalton Pharma Services Business Overview
Table 103. Dalton Pharma Services Dosage Form Development Service Product
Table 104. Dalton Pharma Services Revenue in Dosage Form Development Service Business (2020-2025) & (US$ Million)
Table 105. Dalton Pharma Services Recent Development
Table 106. Douglas Company Details
Table 107. Douglas Business Overview
Table 108. Douglas Dosage Form Development Service Product
Table 109. Douglas Revenue in Dosage Form Development Service Business (2020-2025) & (US$ Million)
Table 110. Douglas Recent Development
Table 111. Corealis Company Details
Table 112. Corealis Business Overview
Table 113. Corealis Dosage Form Development Service Product
Table 114. Corealis Revenue in Dosage Form Development Service Business (2020-2025) & (US$ Million)
Table 115. Corealis Recent Development
Table 116. Upperton Company Details
Table 117. Upperton Business Overview
Table 118. Upperton Dosage Form Development Service Product
Table 119. Upperton Revenue in Dosage Form Development Service Business (2020-2025) & (US$ Million)
Table 120. Upperton Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
Table 124. Authors List of This Report
List of Figures
Figure 1. Dosage Form Development Service Picture
Figure 2. Global Dosage Form Development Service Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Dosage Form Development Service Market Share by Type: 2024 VS 2031
Figure 4. Pre-Formulation Services Features
Figure 5. Late Phase Formulation Development Services Features
Figure 6. Global Dosage Form Development Service Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Dosage Form Development Service Market Share by Application: 2024 VS 2031
Figure 8. Oral Dosage Form Case Studies
Figure 9. Injectable Dosage Form Case Studies
Figure 10. Transdermal Dosage Form Case Studies
Figure 11. Others Case Studies
Figure 12. Dosage Form Development Service Report Years Considered
Figure 13. Global Dosage Form Development Service Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Dosage Form Development Service Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Dosage Form Development Service Market Share by Region: 2024 VS 2031
Figure 16. Global Dosage Form Development Service Market Share by Players in 2024
Figure 17. Global Top Dosage Form Development Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dosage Form Development Service as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Dosage Form Development Service Revenue in 2024
Figure 19. North America Dosage Form Development Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Dosage Form Development Service Market Share by Country (2020-2031)
Figure 21. United States Dosage Form Development Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Dosage Form Development Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Dosage Form Development Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Dosage Form Development Service Market Share by Country (2020-2031)
Figure 25. Germany Dosage Form Development Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Dosage Form Development Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Dosage Form Development Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Dosage Form Development Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Dosage Form Development Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Dosage Form Development Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Dosage Form Development Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Dosage Form Development Service Market Share by Region (2020-2031)
Figure 33. China Dosage Form Development Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Dosage Form Development Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Dosage Form Development Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Dosage Form Development Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Dosage Form Development Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Dosage Form Development Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Dosage Form Development Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Dosage Form Development Service Market Share by Country (2020-2031)
Figure 41. Mexico Dosage Form Development Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Dosage Form Development Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Dosage Form Development Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Dosage Form Development Service Market Share by Country (2020-2031)
Figure 45. Turkey Dosage Form Development Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Dosage Form Development Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Dosage Form Development Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Ascendia Revenue Growth Rate in Dosage Form Development Service Business (2020-2025)
Figure 49. Recipharm Revenue Growth Rate in Dosage Form Development Service Business (2020-2025)
Figure 50. Aurigene Services Revenue Growth Rate in Dosage Form Development Service Business (2020-2025)
Figure 51. Pirama Revenue Growth Rate in Dosage Form Development Service Business (2020-2025)
Figure 52. Serán Revenue Growth Rate in Dosage Form Development Service Business (2020-2025)
Figure 53. SGS Revenue Growth Rate in Dosage Form Development Service Business (2020-2025)
Figure 54. NerPharMa Revenue Growth Rate in Dosage Form Development Service Business (2020-2025)
Figure 55. Scantox Revenue Growth Rate in Dosage Form Development Service Business (2020-2025)
Figure 56. Protheragen-ING Revenue Growth Rate in Dosage Form Development Service Business (2020-2025)
Figure 57. BDD Pharma Revenue Growth Rate in Dosage Form Development Service Business (2020-2025)
Figure 58. Evonik Revenue Growth Rate in Dosage Form Development Service Business (2020-2025)
Figure 59. Dalton Pharma Services Revenue Growth Rate in Dosage Form Development Service Business (2020-2025)
Figure 60. Douglas Revenue Growth Rate in Dosage Form Development Service Business (2020-2025)
Figure 61. Corealis Revenue Growth Rate in Dosage Form Development Service Business (2020-2025)
Figure 62. Upperton Revenue Growth Rate in Dosage Form Development Service Business (2020-2025)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Table 1. Global Dosage Form Development Service Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Pre-Formulation Services
Table 3. Key Players of Late Phase Formulation Development Services
Table 4. Global Dosage Form Development Service Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Dosage Form Development Service Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Dosage Form Development Service Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Dosage Form Development Service Market Share by Region (2020-2025)
Table 8. Global Dosage Form Development Service Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Dosage Form Development Service Market Share by Region (2026-2031)
Table 10. Dosage Form Development Service Market Trends
Table 11. Dosage Form Development Service Market Drivers
Table 12. Dosage Form Development Service Market Challenges
Table 13. Dosage Form Development Service Market Restraints
Table 14. Global Dosage Form Development Service Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Dosage Form Development Service Market Share by Players (2020-2025)
Table 16. Global Top Dosage Form Development Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dosage Form Development Service as of 2024)
Table 17. Ranking of Global Top Dosage Form Development Service Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Dosage Form Development Service Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Dosage Form Development Service, Headquarters and Area Served
Table 20. Global Key Players of Dosage Form Development Service, Product and Application
Table 21. Global Key Players of Dosage Form Development Service, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Dosage Form Development Service Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Dosage Form Development Service Revenue Market Share by Type (2020-2025)
Table 25. Global Dosage Form Development Service Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Dosage Form Development Service Revenue Market Share by Type (2026-2031)
Table 27. Global Dosage Form Development Service Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Dosage Form Development Service Revenue Market Share by Application (2020-2025)
Table 29. Global Dosage Form Development Service Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Dosage Form Development Service Revenue Market Share by Application (2026-2031)
Table 31. North America Dosage Form Development Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Dosage Form Development Service Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Dosage Form Development Service Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Dosage Form Development Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Dosage Form Development Service Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Dosage Form Development Service Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Dosage Form Development Service Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Dosage Form Development Service Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Dosage Form Development Service Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Dosage Form Development Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Dosage Form Development Service Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Dosage Form Development Service Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Dosage Form Development Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Dosage Form Development Service Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Dosage Form Development Service Market Size by Country (2026-2031) & (US$ Million)
Table 46. Ascendia Company Details
Table 47. Ascendia Business Overview
Table 48. Ascendia Dosage Form Development Service Product
Table 49. Ascendia Revenue in Dosage Form Development Service Business (2020-2025) & (US$ Million)
Table 50. Ascendia Recent Development
Table 51. Recipharm Company Details
Table 52. Recipharm Business Overview
Table 53. Recipharm Dosage Form Development Service Product
Table 54. Recipharm Revenue in Dosage Form Development Service Business (2020-2025) & (US$ Million)
Table 55. Recipharm Recent Development
Table 56. Aurigene Services Company Details
Table 57. Aurigene Services Business Overview
Table 58. Aurigene Services Dosage Form Development Service Product
Table 59. Aurigene Services Revenue in Dosage Form Development Service Business (2020-2025) & (US$ Million)
Table 60. Aurigene Services Recent Development
Table 61. Pirama Company Details
Table 62. Pirama Business Overview
Table 63. Pirama Dosage Form Development Service Product
Table 64. Pirama Revenue in Dosage Form Development Service Business (2020-2025) & (US$ Million)
Table 65. Pirama Recent Development
Table 66. Serán Company Details
Table 67. Serán Business Overview
Table 68. Serán Dosage Form Development Service Product
Table 69. Serán Revenue in Dosage Form Development Service Business (2020-2025) & (US$ Million)
Table 70. Serán Recent Development
Table 71. SGS Company Details
Table 72. SGS Business Overview
Table 73. SGS Dosage Form Development Service Product
Table 74. SGS Revenue in Dosage Form Development Service Business (2020-2025) & (US$ Million)
Table 75. SGS Recent Development
Table 76. NerPharMa Company Details
Table 77. NerPharMa Business Overview
Table 78. NerPharMa Dosage Form Development Service Product
Table 79. NerPharMa Revenue in Dosage Form Development Service Business (2020-2025) & (US$ Million)
Table 80. NerPharMa Recent Development
Table 81. Scantox Company Details
Table 82. Scantox Business Overview
Table 83. Scantox Dosage Form Development Service Product
Table 84. Scantox Revenue in Dosage Form Development Service Business (2020-2025) & (US$ Million)
Table 85. Scantox Recent Development
Table 86. Protheragen-ING Company Details
Table 87. Protheragen-ING Business Overview
Table 88. Protheragen-ING Dosage Form Development Service Product
Table 89. Protheragen-ING Revenue in Dosage Form Development Service Business (2020-2025) & (US$ Million)
Table 90. Protheragen-ING Recent Development
Table 91. BDD Pharma Company Details
Table 92. BDD Pharma Business Overview
Table 93. BDD Pharma Dosage Form Development Service Product
Table 94. BDD Pharma Revenue in Dosage Form Development Service Business (2020-2025) & (US$ Million)
Table 95. BDD Pharma Recent Development
Table 96. Evonik Company Details
Table 97. Evonik Business Overview
Table 98. Evonik Dosage Form Development Service Product
Table 99. Evonik Revenue in Dosage Form Development Service Business (2020-2025) & (US$ Million)
Table 100. Evonik Recent Development
Table 101. Dalton Pharma Services Company Details
Table 102. Dalton Pharma Services Business Overview
Table 103. Dalton Pharma Services Dosage Form Development Service Product
Table 104. Dalton Pharma Services Revenue in Dosage Form Development Service Business (2020-2025) & (US$ Million)
Table 105. Dalton Pharma Services Recent Development
Table 106. Douglas Company Details
Table 107. Douglas Business Overview
Table 108. Douglas Dosage Form Development Service Product
Table 109. Douglas Revenue in Dosage Form Development Service Business (2020-2025) & (US$ Million)
Table 110. Douglas Recent Development
Table 111. Corealis Company Details
Table 112. Corealis Business Overview
Table 113. Corealis Dosage Form Development Service Product
Table 114. Corealis Revenue in Dosage Form Development Service Business (2020-2025) & (US$ Million)
Table 115. Corealis Recent Development
Table 116. Upperton Company Details
Table 117. Upperton Business Overview
Table 118. Upperton Dosage Form Development Service Product
Table 119. Upperton Revenue in Dosage Form Development Service Business (2020-2025) & (US$ Million)
Table 120. Upperton Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
Table 124. Authors List of This Report
List of Figures
Figure 1. Dosage Form Development Service Picture
Figure 2. Global Dosage Form Development Service Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Dosage Form Development Service Market Share by Type: 2024 VS 2031
Figure 4. Pre-Formulation Services Features
Figure 5. Late Phase Formulation Development Services Features
Figure 6. Global Dosage Form Development Service Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Dosage Form Development Service Market Share by Application: 2024 VS 2031
Figure 8. Oral Dosage Form Case Studies
Figure 9. Injectable Dosage Form Case Studies
Figure 10. Transdermal Dosage Form Case Studies
Figure 11. Others Case Studies
Figure 12. Dosage Form Development Service Report Years Considered
Figure 13. Global Dosage Form Development Service Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Dosage Form Development Service Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Dosage Form Development Service Market Share by Region: 2024 VS 2031
Figure 16. Global Dosage Form Development Service Market Share by Players in 2024
Figure 17. Global Top Dosage Form Development Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dosage Form Development Service as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Dosage Form Development Service Revenue in 2024
Figure 19. North America Dosage Form Development Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Dosage Form Development Service Market Share by Country (2020-2031)
Figure 21. United States Dosage Form Development Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Dosage Form Development Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Dosage Form Development Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Dosage Form Development Service Market Share by Country (2020-2031)
Figure 25. Germany Dosage Form Development Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Dosage Form Development Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Dosage Form Development Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Dosage Form Development Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Dosage Form Development Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Dosage Form Development Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Dosage Form Development Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Dosage Form Development Service Market Share by Region (2020-2031)
Figure 33. China Dosage Form Development Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Dosage Form Development Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Dosage Form Development Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Dosage Form Development Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Dosage Form Development Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Dosage Form Development Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Dosage Form Development Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Dosage Form Development Service Market Share by Country (2020-2031)
Figure 41. Mexico Dosage Form Development Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Dosage Form Development Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Dosage Form Development Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Dosage Form Development Service Market Share by Country (2020-2031)
Figure 45. Turkey Dosage Form Development Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Dosage Form Development Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Dosage Form Development Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Ascendia Revenue Growth Rate in Dosage Form Development Service Business (2020-2025)
Figure 49. Recipharm Revenue Growth Rate in Dosage Form Development Service Business (2020-2025)
Figure 50. Aurigene Services Revenue Growth Rate in Dosage Form Development Service Business (2020-2025)
Figure 51. Pirama Revenue Growth Rate in Dosage Form Development Service Business (2020-2025)
Figure 52. Serán Revenue Growth Rate in Dosage Form Development Service Business (2020-2025)
Figure 53. SGS Revenue Growth Rate in Dosage Form Development Service Business (2020-2025)
Figure 54. NerPharMa Revenue Growth Rate in Dosage Form Development Service Business (2020-2025)
Figure 55. Scantox Revenue Growth Rate in Dosage Form Development Service Business (2020-2025)
Figure 56. Protheragen-ING Revenue Growth Rate in Dosage Form Development Service Business (2020-2025)
Figure 57. BDD Pharma Revenue Growth Rate in Dosage Form Development Service Business (2020-2025)
Figure 58. Evonik Revenue Growth Rate in Dosage Form Development Service Business (2020-2025)
Figure 59. Dalton Pharma Services Revenue Growth Rate in Dosage Form Development Service Business (2020-2025)
Figure 60. Douglas Revenue Growth Rate in Dosage Form Development Service Business (2020-2025)
Figure 61. Corealis Revenue Growth Rate in Dosage Form Development Service Business (2020-2025)
Figure 62. Upperton Revenue Growth Rate in Dosage Form Development Service Business (2020-2025)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Allergen Detection Market Research Report 2025
Jun 28, 25
Global Electronic Health Tracking System Market Research Report 2025
Jun 28, 25
Global Speciality Optical Fibers Market Research Report 2025
Jun 28, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232